Macular Edema and Macular Degeneration Global Market Report 2025

Macular Edema and Macular Degeneration Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on macular edema and macular degeneration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for macular edema and macular degeneration ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The macular edema and macular degeneration market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Treatment Type: Drug Therapy; Laser Treatment

2) By Application: Macular Edema; Diabetic Macular Edema (DME); Cystoid Macular Edema (CME); Macular Degeneration; Dry age-related macular degeneration; Wet age-related macular degeneration

3) By End User: Hospitals; Clinics; Other End Users

Subsegments:

1) By Drug Therapy: Anti-VEGF (Vascular Endothelial Growth Factor) Injections; Steroid Injections; Oral Medications; Combination Therapy (Anti-VEGF + Steroids)

2) By Laser Treatment: Focal Laser Photocoagulation; Panretinal Photocoagulation (PRP); Subthreshold Laser Therapy; MicroPulse Laser Therapy

Companies Mentioned: F. Hoffmann La Roche Ltd.; Abbvie Inc.; Bayer AG; Novartis AG; GlaxoSmithKline plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.


1. Executive Summary
2. Macular Edema and Macular Degeneration Market Characteristics
3. Macular Edema and Macular Degeneration Market Trends And Strategies
4. Macular Edema and Macular Degeneration Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Macular Edema and Macular Degeneration Growth Analysis And Strategic Analysis Framework
5.1. Global Macular Edema and Macular Degeneration PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Macular Edema and Macular Degeneration Market Growth Rate Analysis
5.4. Global Macular Edema and Macular Degeneration Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Macular Edema and Macular Degeneration Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Macular Edema and Macular Degeneration Total Addressable Market (TAM)
6. Macular Edema and Macular Degeneration Market Segmentation
6.1. Global Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Therapy
Laser Treatment
6.2. Global Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Macular Edema
Diabetic Macular Edema (DME)
Cystoid Macular Edema (CME)
Macular Degeneration
Dry age-related macular degeneration
Wet age-related macular degeneration
6.3. Global Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Other End Users
6.4. Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-VEGF (Vascular Endothelial Growth Factor) Injections
Steroid Injections
Oral Medications
Combination Therapy (Anti-VEGF + Steroids)
6.5. Global Macular Edema and Macular Degeneration Market, Sub-Segmentation Of Laser Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Focal Laser Photocoagulation
Panretinal Photocoagulation (PRP)
Subthreshold Laser Therapy
MicroPulse Laser Therapy
7. Macular Edema and Macular Degeneration Market Regional And Country Analysis
7.1. Global Macular Edema and Macular Degeneration Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Macular Edema and Macular Degeneration Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Macular Edema and Macular Degeneration Market
8.1. Asia-Pacific Macular Edema and Macular Degeneration Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Macular Edema and Macular Degeneration Market
9.1. China Macular Edema and Macular Degeneration Market Overview
9.2. China Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Macular Edema and Macular Degeneration Market
10.1. India Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Macular Edema and Macular Degeneration Market
11.1. Japan Macular Edema and Macular Degeneration Market Overview
11.2. Japan Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Macular Edema and Macular Degeneration Market
12.1. Australia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Macular Edema and Macular Degeneration Market
13.1. Indonesia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Macular Edema and Macular Degeneration Market
14.1. South Korea Macular Edema and Macular Degeneration Market Overview
14.2. South Korea Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Macular Edema and Macular Degeneration Market
15.1. Western Europe Macular Edema and Macular Degeneration Market Overview
15.2. Western Europe Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Macular Edema and Macular Degeneration Market
16.1. UK Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Macular Edema and Macular Degeneration Market
17.1. Germany Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Macular Edema and Macular Degeneration Market
18.1. France Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Macular Edema and Macular Degeneration Market
19.1. Italy Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Macular Edema and Macular Degeneration Market
20.1. Spain Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Macular Edema and Macular Degeneration Market
21.1. Eastern Europe Macular Edema and Macular Degeneration Market Overview
21.2. Eastern Europe Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Macular Edema and Macular Degeneration Market
22.1. Russia Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Macular Edema and Macular Degeneration Market
23.1. North America Macular Edema and Macular Degeneration Market Overview
23.2. North America Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Macular Edema and Macular Degeneration Market
24.1. USA Macular Edema and Macular Degeneration Market Overview
24.2. USA Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Macular Edema and Macular Degeneration Market
25.1. Canada Macular Edema and Macular Degeneration Market Overview
25.2. Canada Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Macular Edema and Macular Degeneration Market
26.1. South America Macular Edema and Macular Degeneration Market Overview
26.2. South America Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Macular Edema and Macular Degeneration Market
27.1. Brazil Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Macular Edema and Macular Degeneration Market
28.1. Middle East Macular Edema and Macular Degeneration Market Overview
28.2. Middle East Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Macular Edema and Macular Degeneration Market
29.1. Africa Macular Edema and Macular Degeneration Market Overview
29.2. Africa Macular Edema and Macular Degeneration Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Macular Edema and Macular Degeneration Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Macular Edema and Macular Degeneration Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Macular Edema and Macular Degeneration Market Competitive Landscape And Company Profiles
30.1. Macular Edema and Macular Degeneration Market Competitive Landscape
30.2. Macular Edema and Macular Degeneration Market Company Profiles
30.2.1. F. Hoffmann La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
31. Macular Edema and Macular Degeneration Market Other Major And Innovative Companies
31.1. Amgen Inc.
31.2. Regeneron Pharmaceuticals Inc.
31.3. Biogen Inc.
31.4. Bausch Health Companies Inc.
31.5. Clover Therapeutics Inc.
31.6. Santen Pharmaceutical Co. Ltd.
31.7. Samsung Bioepis Inc.
31.8. PanOptica Inc.
31.9. Regen X Bio Inc.
31.10. Aerie Pharmaceutical Inc.
31.11. Apellis Pharmaceuticals Inc.
31.12. Kubota Pharmaceutical Holdings Co. Ltd.
31.13. Alimera Sciences Inc.
31.14. Kodiak Sciences Inc.
31.15. Acucela Inc.
32. Global Macular Edema and Macular Degeneration Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Macular Edema and Macular Degeneration Market
34. Recent Developments In The Macular Edema and Macular Degeneration Market
35. Macular Edema and Macular Degeneration Market High Potential Countries, Segments and Strategies
35.1 Macular Edema and Macular Degeneration Market In 2029 - Countries Offering Most New Opportunities
35.2 Macular Edema and Macular Degeneration Market In 2029 - Segments Offering Most New Opportunities
35.3 Macular Edema and Macular Degeneration Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings